Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DENN domain-containing protein 6B (DENND6B) is a cytosolic guanine nucleotide exchange factor mainly for the small GTPase RAB14, and to a lesser extent RAB35[1][5][9]. It is involved in vesicle-mediated transport and endosomal trafficking, facilitating the exchange of GDP for GTP on Rab proteins that regulate membrane trafficking[1][5][7][8]. DENND6B is expressed in human tissues and is predicted to function in recycling endosomes, where it supports the regulation of intracellular membrane compartments and vesicle dynamics[1][8][9]. While its direct connection to human diseases is not well defined, DENND6B is important for normal vesicular trafficking physiology rather than being a druggable therapeutic target in current clinical contexts[1][7][8][9].
Drugs targeting this molecule—if future ones exist—would likely modulate guanine nucleotide exchange activity, specifically influencing Rab GTPase-regulated trafficking, but no such drugs are described
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DENN domain-containing protein 6B (DENND6B).